Activation of the Shh signaling pathway predisposes individuals to the development of the nevoid basal cell carcinoma syndrome (NBCCS), an autosomal-dominant disorder characterized by PTCH mutations (84–86). This evidence concerns the gene PTCH1 and nevoid basal cell carcinoma syndrome.